IBB has fallen less than the S&P 500 this year, and may beat again in 2023.
Investors focused on long-term themes often include an allocation to this genetic revolution.
Which biotech ETF is the better choice?
ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.
Which biotech/genomics ETF is the better play?
Plus, several funds undergo name and index changes.
Plus, iShares lowered expense ratios on two of its ETFs.
A review of fund flows and key trends around microcaps, uranium and biotech.
Interest rates hit their highest levels in a year on Wednesday, putting pressure on long-duration assets.